SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-22-000130
Filing Date
2022-12-20
Accepted
2022-12-20 16:59:55
Documents
1
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167157357332535.html 4  
1 FORM 4 wf-form4_167157357332535.xml 4 8993
  Complete submission text file 0001739614-22-000130.txt   10918
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Reporting) CIK: 0001366074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 221475566

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037
Business Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037 858-759-1499
Lappe Family Trust (Reporting) CIK: 0001821266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 221475565